Please provide your email address to receive an email when new articles are posted on . Insertable cardiac monitoring was estimated to be cost-effective for AF detection in the U.S. This finding was ...

Abbott's Assert-IQ offers the world's longest battery life† for an insertable cardiac monitor (ICM) The latest addition to Abbott's portfolio of connected health devices, the Assert-IQ ICM offers long ...

Jennifer Adamy, a 43-year-old cardiac nurse living in New Smyrna Beach, Florida, was very familiar with the signs of heart problems. So, when she started experiencing symptoms of irregular heart ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced the FDA cleared its insertable cardiac monitor for diagnosis and evaluation of irregular ...

An arrhythmia is an abnormal heart rhythm that develops when disease or injury disrupts the heart’s electrical signals, causing the heart to beat erratically. Arrhythmias are very common, and nearly ...

Abbott has secured a CE mark approval in Europe for its long-term insertable cardiac monitor, designed to help monitor a patient’s heart rhythms remotely for up to six years. The Bluetooth-equipped ...

Clinicians insert the Reveal LINQ Insertable Cardiac Monitor in the upper left side of a patient’s chest during a minimally invasive procedure. The implanted device allows clinicians to continuously ...

Abbott Laboratories landed CE mark for two versions of its Assert-IQ insertable cardiac monitor (ICM), one with a three-year battery life, the other lasting six years. Designed for long-term remote ...